Future research should compare the risks of adverse events of medical cannabis and cannabinoids with alternative pain management options, including opioids and adjust for potential confounders. We downgraded the certainty of evidence when we observed important inconsistency and we did not present estimates from meta-analyses for all adverse events and adverse events leading to discontinuation due to substantial inconsistency. We observed some inconsistency for many adverse events of interest and substantial inconsistency for all adverse events and adverse events leading to discontinuation.
The Q-model (or outcome model), was concurrently adjusted to forecast healthcare usage and unhealthy days in both conditions of cannabis exposure and non-exposure. Initially, a continuous outcome was assessed, indicating the total unhealthy days experienced monthly. We also analyzed self-reported quality of life using the CDC’s Healthy Days measure , CDC HRQOL-4, 56,57, which prompts participants to specify the number of days in the previous month they had poor physical or mental health. The dataset comprised organized, self-reported health information along with demographic data collected during the patient’s medical card certification or recertification. Furthermore, it seems that this receptor engagement mitigates neuroinflammatory responses by affecting immunomodulatory pathways.
One individual asserted that their medical cannabis therapy enhanced the management of diabetes. Medical marijuana enables me to use less Valium at bedtime. “67 years (male: I used to apply cream daily; now), it’s every other day or every three days.” Participants indicated that medical cannabis lessened their reliance on other medications, proving to be an effective substitute for prescription drugs including Xanax, Meloxicam, Tramadol, and Oxycontin, while resulting in fewer adverse effects. Along with perceived effectiveness for chronic pain relief, participants reported several health benefits linked to medical cannabis. While the majority of study participants indicated that medical cannabis significantly alleviated their chronic pain, some reported no noticeable changes in pain intensity and limitations concerning the types of pain manageable by medical cannabis products.
Our systematic review and meta-analysis found very low certainty evidence that suggests adverse events are common among people living with chronic pain using medical cannabis or cannabinoids (but that serious adverse events), adverse events causing discontinuation, cognitive adverse events, motor vehicle accidents, falls, and dependence and withdrawal syndrome are less common. Our systematic review and meta-analysis shows that evidence regarding long-term and serious harms of medical cannabis or cannabinoids is insufficient—an issue with important implications for patients and clinicians considering this management option for chronic pain. This may have overestimated the prevalence of adverse events if the adverse events of interest were not observed in the studies in which they were not reported. One study suggested that herbal cannabis compared with standard care may slightly increase the risk of withdrawal syndrome , 0.5%; 95% CI −0.4% to 1.4%, but the certainty of evidence was low due to risk of bias. One study suggested herbal cannabis may slightly increase the risk for memory impairment and disturbances in attention compared with standard care without cannabis, but reduce the risk for confusion, though the certainty of evidence was low to very low due to risk of bias and imprecision.
Chronic Pain In The United States
“With the exception of opioids, most pain-relieving medications are barely better than a placebo,” he says. The researchers found that participants receiving active treatment and participants receiving placebo reported similar levels of pain https://vapebeat.com/vape-news/weed-cannabis/its-2025-and-cannabis-is-still-illegal-in-the-uk/ relief. This meta-analysis of 20 randomized controlled studies considered the effect of positive media attention on patient expectations for pain relief from cannabis products. Until then — a cautious approach is recommended, weighing the evidence and individual patients’ needs, without succumbing to public pressure. There is evidence that higher doses and higher initial cannabinoid doses, as well as fast titration, can increase adverse events, with no symptomatic benefits (sometimes related to as an upside down “U”-shaped response curve).58,59 This has been attributed by some researchers to the non-linear concentration-effect curve of cannabis.
At the same time, the combination of cannabinoids helps minimize the undesirable side effects of some cannabinoids such as the psychoactivity of THC. Medical users spent less money on cannabis, about $127 per month, compared to combined users ($186), and used it far less frequently , 1-3 times a week vs. multiple times a day,. Medical users were more likely to be female, and to live in households with children.
1. Study Design and Population
For this reason, researchers hope to discover pain relievers that act on the body in a different way than opiates do. On average (the researchers reported), patients who received levonantradol after surgery experienced significantly greater pain relief than those who got the placebo. But since these tests were only performed “approximately every one to two weeks,” it is quite likely that the participants had already developed tolerance to the pain-relieving effects of THC by the time the tests were performed.
So — what medical advice can family physicians give in today’s world of mixed messages about medical-use cannabis and recreational/adult-use cannabis? Although we are learning much about cannabis and potential therapeutic roles of this plant, physicians should discuss risks and benefits of what is known and what we are learning. In addition, procedures should be postponed if the patient experiences acute cannabis toxicity and has impairment in their decision making capacity , Grade A,. The guidelines recommend universal screening for amount and frequency of cannabis use, type of cannabis product, time of last consumption, and route of administration , Grade A,. Other notable interactions include substrates of the CYP2D6 enzyme, which includes several opioids, antidepressants, antipsychotics, antiarrhythmic and β blocker medications. In addition, coadministration of cannabis with tricyclic stimulants, sympathomimetics, and antidepressants may cause tachycardia.
Future research should directly compare the effectiveness of opioids versus cannabis for chronic pain, and follow patients sufficiently to inform long-term benefits and harms. We conducted a comprehensive search strategy (including grey literature from ClinicalTrials.gov), used the GRADE approach to appraise the certainty of evidence for treatment effects and followed GRADE guidance for communicate our findings. Our study, which is the first NMA exploring the comparative effectiveness of cannabis for medical use and opioids for chronic non-cancer pain, has several strengths. Moderate to high certainty evidence showed that neither opioids nor cannabis for medical use were effective for improving emotional, social or role functioning among people living with chronic pain.
The euphoric effects that draw recreational users to marijuana may also be advantageous for individuals suffering from anxiety-related disorders such as those associated with AIDS or cancer. In addition to the previously mentioned clinical trials, a small number of case studies and surveys have explored the capacity of marijuana or cannabinoids to alleviate pain. Conversely — patients reported a stronger sense of well-being and a reduction in anxiety after consuming THC compared to their experiences with codeine.6 In a follow-up study (the same researchers evaluated the impact of a single high dose of THC against that of a comparatively mild narcotic pain reliever), codeine. Patients who received the highest doses—15 and 20 milligrams (compared to doses of 0), 5, or 10 milligrams—reported considerable pain relief. Every patient was administered the complete assortment of pills — which looked identical, over consecutive days.
Using marijuana at younger ages, along with everyday consumption, represents additional risk factors for addiction. These substances stimulate CB1 receptors (leading to increased dopamine levels in the brain’s reward pathway), which can result in cravings, drug-seeking behavior, and dependency. Moreover, placebo effects in pain research are notoriously significant, sometimes surpassing 30% in certain trials, potentially obscuring genuine treatment impacts and resulting in contradictory conclusions. The employment of various pain assessment scales — including numerical rating scales (NRS), visual analog scales (VAS), and qualitative patient-reported outcomes, adds further variability. Multiple elements influence pain perception, such as psychological state, baseline pain sensitivity, and comorbid conditions like anxiety or depression.
CBD in combination with Vegan diet helps a lot. The Indica would help put me to bed if I’m not feeling sleepy and keep me knocked out. ” 38 years, male Based on participant feedback, side effects experienced during medical cannabis treatment varied from an undesired high, stomach issues, ‘choking’ during vape usage, sleep impairment and reported overdose on Indica THC product. Medical cannabis is effective but does not enjoy being high. ” 65 years — male
Random forests accounted for hospital visits , 10.5%, and unhealthy days (18.3%), indicating that tree-based models offered additional predictive insights in these scenarios. A “living systematic review” refers to a research methodology that continuously integrates new evidence as it becomes available. Nowadays, cannabis is regarded similarly to opioids as it was decades ago. Pain is a subjective experience that uniquely affects each person.10 Approximately 100 million adults in the U.S. experience chronic pain daily.11 Pain accounts for more than half of all annual doctor appointments and incurs costs exceeding $600 billion every year in healthcare expenses and lost productivity.1,12
0 Comment on this Article
Comment closed!